### Addressing Racial Disparities in Kidney Care in the U.S. The U.S. is currently making significant changes to address racial disparities in kidney care. One major step is the revision of the estimated glomerular filtration rate (eGFR) equation, which previously included a race-based adjustment. This adjustment often resulted in higher eGFR scores for Black patients, potentially delaying necessary treatments like dialysis or kidney transplants. The new, race-neutral eGFR equations aim to provide a more accurate assessment of kidney function without considering race. This change is expected to reduce disparities in treatment recommendations and outcomes for Black patients. The move towards race-neutral equations has been driven by nephrologists, medical students, and organizations like the National Kidney Foundation and the American Society of Nephrology. These groups have questioned the scientific basis for the race adjustment and advocated for its removal. The new equations, introduced in 2021, either rely solely on creatinine levels or include an additional test for cystatin C, another marker of kidney function. While the new equations are slightly less precise, they are seen as a crucial step towards more equitable kidney care. The broader goal is to address systemic racism in healthcare, which affects Black patients' health outcomes in various ways, from chronic stress to limited access to healthcare resources. The revision of the eGFR equation is a meaningful step, but experts agree that more extensive efforts are needed to fully address these deep-rooted disparities.###